BF
Bjorn Frendeus at BioInvent International (STO: BINV)
Operator of a research-based pharmaceutical company intended to develop antibody-based drug therapies for the treatment of cancer
ContactFirm
BioInvent International (STO: BINV)
Location
Global
Investment Stage
Growth
Geographic Focus
Global
About Bjorn Frendeus
Enriching content...
Similar Investors in Global
Contact BioInvent International (STO: BINV)
Get in touch for investment criteria and partnership opportunities.
Contact